financeMarketWatch
Moderna’s stock doubles on promising cancer-vaccine results
August 19, 2026
The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
GN Media aggregates headlines — read the full story on MarketWatch.
Read full story on MarketWatch
